Vascular mild cognitive impairment: concept, definition, and directions for future studies

Arturo Consoli1, Marco Pasi, Leonardo Pantoni

  • 1Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy.

Insights

Early identification of vascular mild cognitive impairment (vascular MCI) is crucial. Prompt treatment of vascular conditions can slow or halt cognitive decline and progression to dementia.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Cognitive Science

Background:

  • Vascular mild cognitive impairment (vascular MCI) is a condition resulting from vascular diseases, characterized by cognitive deficits not meeting dementia criteria.
  • The clinical, neuroimaging, and natural history of vascular MCI are still being defined, similar to neurodegenerative MCI.
  • Early detection of vascular MCI is vital for intervention.

Purpose of the Study:

  • To highlight the importance of identifying early-stage vascular MCI.
  • To emphasize the potential for slowing or halting disease progression through vascular risk factor management.
  • To advocate for longitudinal studies on vascular MCI natural history and dementia transition.

Main Methods:

  • This study is a conceptual overview and call for research, not an empirical investigation.
  • It synthesizes current understanding of vascular MCI based on existing medical knowledge.
  • It proposes future research directions, particularly longitudinal studies.

Main Results:

  • Vascular MCI presents with cognitive deficits due to vascular disease, without loss of basic functional autonomy.
  • Aggressive management of vascular risk factors and diseases can potentially slow or halt the progression of vascular MCI.
  • Further longitudinal research is needed to understand the natural history and factors leading to dementia.

Conclusions:

  • Identifying vascular MCI early is critical for effective management.
  • Intervention targeting vascular health can modify the course of cognitive impairment.
  • Longitudinal studies are essential to fully characterize vascular MCI and its progression to dementia.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.